Secular trends of Blood stream infections in allogeneic hematopoietic cell transplant recipients 72 hours prior to death
- 9 May 2021
- journal article
- research article
- Published by Wiley in Transplant Infectious Disease
- Vol. 23 (4), e13631
- https://doi.org/10.1111/tid.13631
Abstract
Introduction Blood stream infections (BSI) frequently cause morbidity and mortality in allogeneic (allo) hematopoietic cell transplant (HCT) recipients. Characteristics of causative organisms shortly before death have not been previously described. Early treatment with antimicrobial agents targeting the recent surge in multidrug‐resistant (MDR) pathogens may lead to better outcomes. Methods This is retrospective study including 529 allo HCT recipients who died between 2000‐ 2013. All patients who had BSI that happened 72 hours before to death were included. BSI’s and criteria for antimicrobial resistance were defined according to the Centers for Disease Control and Prevention, and the National Healthcare Safety Network surveillance criteria. Results Overall, 104 BSI were identified from 91 patients. Bacterial infections accounted for 87% of the infections which were comprised by 37% gram negative organisms and 50% gram positive bacteria. The most common species were Enterococcus (30%), Staphylococcus (16%), and Pseudomonas (16%). Most enterococci were vancomycin‐resistant (87%) , 100% of Staphylococci were resistant to methicillin, and 64% of Pseudomonas were MDR. Over time there was a significant increase in vancomycin‐resistant Enterococcal (p=0.01) and gram‐negative BSI (p=0.01). Blood stream infections were either the primary or secondary cause of death in 53% of patients. Conclusions In allo HCT recipients, vancomycin‐resistant enterococcal infections caused the majority of BSI 72 hours prior to death. Our findings provide information that may guide empiric antibiotic coverage in critically‐ill HCT recipients.Keywords
This publication has 36 references indexed in Scilit:
- Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell TransplantJAMA Network Open, 2020
- Prevalence and risk factors for bloodstream infection present on hospital admissionJournal of Infection Prevention, 2017
- An 8-year survey of strains identified in blood cultures in a clinical haematology unitClinical Microbiology & Infection, 2014
- Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipientsInfection, 2011
- Canadian Clinical Practice Guidelines for Invasive Candidiasis in AdultsCanadian Journal of Infectious Diseases and Medical Microbiology, 2010
- Blood Stream Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Reemergence of Gram-Negative Rods and Increasing Antibiotic ResistanceTransplantation and Cellular Therapy, 2009
- Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortalityBone Marrow Transplantation, 2007
- Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipientsBone Marrow Transplantation, 2007
- Pre‐ and post‐engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipientsTransplant Infectious Disease, 2005
- Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000Annals of Hematology, 2004